Name
Session IX: Indolent B-Cell Lymphoma
Date & Time
Friday, September 11, 2026, 10:25 AM - 11:47 AM
Description
Session IX: Indolent B-Cell Lymphoma
Session Chairs: Kim Linton, MBChB, MRCP, PhD and Gilles A. Salles, MD, PhD
How to Incorporate Bispecific Abs in FL | John M. Burke, MD | SCRI at Rocky Mountain Cancer Centers, Denver, Colorado, USA
Can We Personalize Care in FL | Kim Linton, MBChB, MRCP, PhD | The University of Manchester, Manchester, United Kingdom
Risk Stratification of FL in the Modern Era | Gilles A. Salles, MD, PhD | Memorial Sloan Kettering Cancer Center, New York, New York, USA
With 5 Years of Follow Up, Can We Claim CART Can Cure FL? | Paolo Caimi, MD, MBA | Cleveland Clinic, Cleveland, Ohio, USA
Oral Abstract | TBD | Speaker | Affiliation
Speakers
Gilles Salles, Memorial Sloan Kettering Cancer Center
John Burke, SCRI at Rocky Mountain Cancer Centers
Paolo Caimi, Cleveland Clinic
Kim Linton, The University of Manchester
John Burke, SCRI at Rocky Mountain Cancer Centers
Paolo Caimi, Cleveland Clinic
Kim Linton, The University of Manchester
Location Name
General Assembly, Level 3 GRB Convention Center